Delivery Order SPE2DB24D2011-SPE2DB24FBQUB

Award Date 8/8/24
Potential Completion Date 8/9/24
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VIMPAT 150 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA). The contract has a ceiling value of $3,336.47 and an ultimate completion date of January 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside....
This federal contract award is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 22, 2022, with a ceiling value of $10,585.23. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VIMPAT 200 MG TABLET 60S, a pharmaceutical product. The $2,501.60 firm-fixed-price contract has a completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medication tablets under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,682.43, is for the supply of VIMPAT 100 MG TABLET 60S, a prescription medication. The contract has an ultimate completion date of February 20, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,438.46 firm fixed-price delivery order is for the supply of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,662.19, is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of May 30, 2024 and is a firm fixed-price, delivery order type contract. The contract was not set aside for any specific business category. AmerisourceBergen Drug...
This federal contract award is for the delivery of VIMPAT 150 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 31, 2025. This single-award IDC serves as the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VIMPAT 200 mg Tablet 60s, a pharmaceutical product. The contract has a ceiling value of $2,906.80 and a period of performance through August 1, 2024. It is a firm-fixed-price contract and was not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide the required medication to support military treatment facilities...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a pharmaceutical product called VIMPAT 10 MG/ML SOLUTION 200ML. The contract, valued at $1,292.15, has an ultimate completion date of April 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEUY6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,550.61 firm fixed-price delivery order is for the supply of VIMPAT 150 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $2,550.61 and a completion date of June 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBQUB
    Delivery Order

This contract award is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp's Corporate Office division. The contract has a ceiling value of $2,813.85 and is a Firm Fixed Price Delivery Order that runs through August 9, 2024. The award was made on August 8, 2024, and there is no set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support military treatment programs and facilities worldwide.

Generated 11/7/24, 9:16 AM